EFFECTS AND PLASMA-LEVELS OF PROPRANOLOL AND METOPROLOL IN HYPER-THYROID PATIENTS

被引：29

作者：

NILSSON, OR ^{[1
]}

MELANDER, A ^{[1
]}

TEGLER, L ^{[1
]}

机构：

[1] UNIV LUND,MALMO GEN HOSP,DEPT CLIN PHARMACOL,S-21401 MALMO,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1980年 / 18卷 / 04期

关键词：

D O I：

10.1007/BF00561388

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：315 / 320

页数：6

共 26 条

[1] RADIOIMMUNOASSAY FOR 3,3',5'-L-TRIIODOTHYRONINE (REVERSE-T3) - ASSESSMENT OF THYROID-GLAND CONTENT AND SERUM MEASUREMENTS IN CONDITIONS OF NORMAL AND ALTERED THYROIDAL ECONOMY AND FOLLOWING ADMINISTRATION OF THYROTROPIN RELEASING HORMONE (TRH) AND THYROTROPIN (TSH) [J].

BURMAN, KD ;

DIMOND, RC ;

WRIGHT, FD ;

EARLL, JM ;

BRUTON, J ;

WARTOFSKY, L .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 44 (04) :660-672

[2]

CROOKS J, 1959, Q J MED, V28, P211

[3]

ERVIK M, 1975, ACTA PHARMACOL TOX, V36, P136

[4] BETA-ADRENERGIC POTENTIATION OF THE INCREASED INVITRO ACCUMULATION OF CYCLOLEUCINE BY RAT THYMOCYTES INDUCED BY TRIIODOTHYRONINE [J].

ETZKORN, J ;

HOPKINS, P ;

GRAY, J ;

SEGAL, J .

JOURNAL OF CLINICAL INVESTIGATION, 1979, 63 (06) :1172-1180

[5] PROPRANOLOL, TRIIODOTHYRONINE, REVERSE TRIIODOTHYRONINE AND THYROID-DISEASE [J].

FEELY, J ;

ISLES, TE ;

RATCLIFFE, WA ;

CROOKS, J .

CLINICAL ENDOCRINOLOGY, 1979, 10 (05) :531-538

[6]

FEELY J, 1978, BRIT J CLIN PHARMACO, V6, pP446

[7] EFFECTS OF BETA BLOCKADE ON PERIPHERAL MANIFESTATIONS OF THYROTOXICOSIS [J].

GROSSMAN, W ;

ROBIN, NI ;

JOHNSON, LW ;

BROOKS, H ;

SELENKOW, HA ;

DEXTER, L .

ANNALS OF INTERNAL MEDICINE, 1971, 74 (06) :875-+

[8] THYROXINE AND TRIIODOTHYRONINE LEVELS IN HYPERTHYROID PATIENTS DURING TREATMENT WITH PROPRANOLOL [J].

HARROWER, ADB ;

FYFFE, JA ;

HORN, DB ;

STRONG, JA .

CLINICAL ENDOCRINOLOGY, 1977, 7 (01) :41-44

[9]

HELLMAN R, 1977, NEW ENGL J MED, V297, P671

[10]

HEYMA P, 1980, BRIT MED J, V281, P24, DOI 10.1136/bmj.281.6232.24

← 1 2 3 →